InsidersTradesSigma
한올바이오파마: directors' dealings · South Korea · DART (FSS)
DART:company-da13c9KR·DART (FSS)Mcap 2220.5Bn€
Explore the full insider trade history of 한올바이오파마, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Market capitalisation: €2,220.5bn. The latest transaction was reported on 6 May 2026 — Mixed. Among the most active insiders: 국민연금공단. All data is accessible without an account.
5
Insider Decl.
0
Thresholds
€19m
4 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
41450.00 €
Income statement
Revenue155.18 Bn€
Gross profit80.86 Bn€52% margin
Net income−5.56 Bn€-3.6% margin
Balance sheet & cash
Market cap2220.52 Bn€
Total debt31.92 Bn€
Free Cash Flow−16.46 Bn€
Last declaration on 6 May 2026
Declarations5 total
5 of 5 declarations